当前位置： SCI文献检索 > Hepatology International期刊下所有文献 > Feasibility of liver graft procurement with donor gallbladder preservation in living donor liver transplantation.

Feasibility of liver graft procurement with donor gallbladder preservation in living donor liver transplantation.

Abstract：

OBJECTIVE:Cholecystectomy is routinely performed at most transplant centers during living donor liver transplantation (LDLT). This study was performed to evaluate the feasibility of liver graft procurement with donor gallbladder preservation in LDLT. METHODS:Eighty-nine LDLTs (from June 2006 to Dec 2012) were retrospectively analyzed at our hospital. The surgical approach for liver graft procurement with donor gallbladder preservation was assessed, and the anatomy of the cystic artery, the morphology and contractibility of the preserved gallbladder, postoperative symptoms, and vascular and biliary complications were compared among donors with or without gallbladder preservation. RESULTS:Twenty-eight donors (15 right and 13 left-liver grafts) successfully underwent liver graft procurement with gallbladder preservation. Among the 15 right lobectomy donors, for 12 cases (80.0 %) the cystic artery originated from right hepatic artery. From the left hepatic artery and proper hepatic artery accounted for 6.7 % (1/15), respectively. Postoperative symptoms among these 28 donors were slight, although donors with cholecystectomy often complained of fatty food aversion, dyspepsia, and diarrhea during an average follow-up of 58.6 (44-78) months. The morphology and contractibility of the preserved gallbladders were comparable with normal status; the rate of contraction was 53.8 and 76.7 %, respectively, 30 and 60 min after ingestion of a fatty meal. Biliary and vascular complications among donors and recipients, irrespective of gallbladder preservation, were not significantly different. CONCLUSIONS:These data suggest that for donors compliant with anatomical requirements, liver graft procurement with gallbladder preservation for the donor is feasible and safe. The preserved gallbladder was assessed as functioning well and postoperative symptoms as a result of cholecystectomy were significantly reduced during long-term follow-up.

journal_name

Hepatol Int

journal_title

Hepatology international

authors

Dong JH,Ye S,Duan WD,Ji WB,Liang YR

doi

10.1007/s12072-015-9628-y

subject

Has Abstract

pub_date

2015-10-01 00:00:00

pages

603-11

issue

4

eissn

1936-0533

issn

1936-0541

pii

10.1007/s12072-015-9628-y

journal_volume

9

pub_type

杂志文章

相关文献

Hepatology International文献大全
  • Renal function and severity of bright liver. Relationship with insulin resistance, intrarenal resistive index, and glomerular filtration rate.

    abstract：AIMS:Relationships of renal function and liver disease are described in acute and chronic liver failure. The aim of the study is to investigate which relationship, if any, is present between severity of non-alcoholic fatty liver disease (NAFLD), assessed by bright liver score (BLS) versus mild-moderate renal insufficie...

    journal_title：Hepatology international

    pub_type： 杂志文章

    doi：10.1007/s12072-011-9254-2

    authors： Catalano D,Trovato GM,Martines GF,Pirri C,Trovato FM

    更新日期：2011-09-01 00:00:00

  • Hepatic stellate cells: fibrogenic, regenerative or both? Heterogeneity and context are key.

    abstract：:Since their original identification, our understanding of the role of hepatic stellate cells in both health and disease continues to grow. Numerous studies have delineated the role of stellate cell activation in contributing to the pool of myofibroblasts responsible for liver fibrosis, and these have resulted in the d...

    journal_title：Hepatology international

    pub_type： 杂志文章,评审

    doi：10.1007/s12072-016-9758-x

    authors： Bansal MB

    更新日期：2016-11-01 00:00:00

  • Incidence and risk factors for surveillance failure in patients with regular hepatocellular carcinoma surveillance.

    abstract：BACKGROUND:Initial presentation of hepatocellular carcinoma (HCC) at an advanced stage in patients under a regular surveillance program is a devastating problem. AIMS:We assessed the prevalence and factors associated with this surveillance failure. METHODS:A total of 304 HCC patients who received regular surveillance...

    journal_title：Hepatology international

    pub_type： 杂志文章

    doi：10.1007/s12072-013-9462-z

    authors： Sinn DH,Yi J,Choi MS,Choi D,Gwak GY,Paik YH,Lee JH,Koh KC,Paik SW,Yoo BC

    更新日期：2013-10-01 00:00:00

  • CSH guidelines for the diagnosis and treatment of drug-induced liver injury.

    abstract：:Drug-induced liver injury (DILI) is an important clinical problem, which has received more attention in recent decades. It can be induced by small chemical molecules, biological agents, traditional Chinese medicines (TCM), natural medicines (NM), health products (HP), and dietary supplements (DS). Idiosyncratic DILI i...

    journal_title：Hepatology international

    pub_type： 社论

    doi：10.1007/s12072-017-9793-2

    authors： Yu YC,Mao YM,Chen CW,Chen JJ,Chen J,Cong WM,Ding Y,Duan ZP,Fu QC,Guo XY,Hu P,Hu XQ,Jia JD,Lai RT,Li DL,Liu YX,Lu LG,Ma SW,Ma X,Nan YM,Ren H,Shen T,Wang H,Wang JY,Wang TL,Wang XJ,Wei L,Xie Q,Xie W,

    更新日期：2017-05-01 00:00:00

  • Acute kidney injury in hepatitis B-related acute-on-chronic liver failure without preexisting liver cirrhosis.

    abstract：BACKGROUND AND AIM:Acute kidney injury (AKI), as defined by the Acute Kidney Injury Network, has been widely investigated in decompensated liver cirrhosis patients. AKI is frequently progressive and independently associated with mortality in these patients. However, in the Asia-Pacific region, the majority of cases of ...

    journal_title：Hepatology international

    pub_type： 杂志文章

    doi：10.1007/s12072-015-9636-y

    authors： Huang Z,Lin C,Fang J,Wang N,Zhou R,Pan C

    更新日期：2015-07-01 00:00:00

  • Epigenetic histone modifications in a clinically relevant rat model of chronic ethanol-binge-mediated liver injury.

    abstract：PURPOSE:Ethanol binge augments liver injury after chronic ethanol consumption in humans, but the mechanism behind the enhanced liver injury by ethanol binge is not known. In this study we used a clinically relevant rat model in which liver injury is amplified by binge after chronic ethanol treatment and investigated th...

    journal_title：Hepatology international

    pub_type： 杂志文章

    doi：10.1007/s12072-014-9546-4

    authors： Aroor AR,Restrepo RJ,Kharbanda KK,Shukla SD

    更新日期：2014-09-01 00:00:00

  • Treatment of chronic hepatitis C genotype 3 with Sofosbuvir-based therpy: a real-life study.

    abstract：BACKGROUND AND AIMS:Recently, Sofosbuvir was launched in India at affordable cost. We conducted a real-life study to determine the efficacy and safety of Sofosbuvir plus Ribavirin, with and without peginterferon-alfa 2a, in patients with chronic hepatitis C (CHC) genotype 3, the commonest genotype in South Asia. METHO...

    journal_title：Hepatology international

    pub_type： 杂志文章

    doi：10.1007/s12072-017-9794-1

    authors： Sidhu SS,Malhi NS,Goyal O,Singh R,Dutta U,Grover R,Sidhu JS,Nanda V,Saluja H,Bansal A,Singh G,Sehgal A,Kishore H,Sidhu S

    更新日期：2017-05-01 00:00:00

  • Predicting clinical outcomes in patients with HBsAg-positive chronic hepatitis.

    abstract：BACKGROUND AND AIMS:The progression of HBsAg-positive chronic hepatitis is insidious and unpredictable. Identification of factors leading to either a benign or more serious clinical outcome may assist in decision making for antiviral therapy. METHODS:From 1989 to 1998, 130 untreated patients with chronic hepatitis wer...

    journal_title：Hepatology international

    pub_type： 杂志文章

    doi：10.1007/s12072-015-9651-z

    authors： Tong MJ,Huynh TT,Siripongsakun S,Chang PW,Tong LT,Ha YP,Mena EA,Weissman MF

    更新日期：2015-10-01 00:00:00

  • Hepatitis B virus reactivation in patients receiving cancer chemotherapy: natural history, pathogenesis, and management.

    abstract：:Chronic hepatitis B virus (HBV) infection is endemic in the Asian-Pacific region, and reactivation of HBV post-cancer chemotherapy has become an emerging clinical challenge. Patients with detectable serum HBV DNA before chemotherapy and those receiving intensive chemotherapy are particularly at a risk of HBV reactivat...

    journal_title：Hepatology international

    pub_type： 杂志文章

    doi：10.1007/s12072-011-9279-6

    authors： Liu CJ,Chen PJ,Chen DS,Kao JH

    更新日期：2013-06-01 00:00:00

  • Biology of portal hypertension.

    abstract：:Portal hypertension develops as a result of increased intrahepatic vascular resistance often caused by chronic liver disease that leads to structural distortion by fibrosis, microvascular thrombosis, dysfunction of liver sinusoidal endothelial cells (LSECs), and hepatic stellate cell (HSC) activation. While the basic ...

    journal_title：Hepatology international

    pub_type： 杂志文章,评审

    doi：10.1007/s12072-017-9826-x

    authors： McConnell M,Iwakiri Y

    更新日期：2018-02-01 00:00:00

  • Hepatitis B reactivation after chemotherapy: two decades of clinical research.

    abstract：:Hepatitis due to hepatitis B virus reactivation after cytotoxic or immunosuppressive therapy is a serious cause of liver-related morbidity and mortality. With the characterization of the underlying pathogenesis, much progress in the management of this important clinical problem has been made in the past 2 decades. By ...

    journal_title：Hepatology international

    pub_type： 杂志文章

    doi：10.1007/s12072-008-9056-3

    authors： Lau GK

    更新日期：2008-06-01 00:00:00

  • An imbalance between stellate cells and γδT cells contributes to hepatocellular carcinoma aggressiveness and recurrence.

    abstract：PURPOSE:The diagnostic potential of hepatic stellate cells (HSCs) and γδT cells for patients with hepatocellular carcinoma (HCC) and their synergistic contributions to the prognosis of these patients have not yet been investigated. The aim of this study was to elucidate the prognostic value of these cells in HCC. METH...

    journal_title：Hepatology international

    pub_type： 杂志文章

    doi：10.1007/s12072-019-09969-w

    authors： Zhou BY,Gong JH,Cai XY,Wang JX,Luo F,Jiang N,Gong JP,Du CY,Liao R

    更新日期：2019-09-01 00:00:00

  • New drugs for NAFLD: lessons from basic models to the clinic.

    abstract：:The term nonalcoholic fatty liver disease (NAFLD) comprises a spectrum of increasingly harmful conditions ranging from nonalcoholic fatty liver (NAFL) to nonalcoholic steatohepatitis (NASH) to liver fibrosis and end-stage cirrhosis. NAFLD is the currently most common form of chronic liver disease in both adults and ch...

    journal_title：Hepatology international

    pub_type： 杂志文章,评审

    doi：10.1007/s12072-019-10001-4

    authors： Reimer KC,Wree A,Roderburg C,Tacke F

    更新日期：2020-01-01 00:00:00

  • The influence of pioglitazone on the plasma amino acid profile in patients with nonalcoholic steatohepatitis (NASH).

    abstract：BACKGROUND AND AIMS:The peroxisome proliferator-activated receptor-γ (PPAR-γ) ligand, piglitazone, enhances the degradation of branched-chain amino acids (BCAAs) in adipose tissue. However, it remains unknown whether pioglitazone influences the plasma amino acids (AA) profile in patients with nonalcoholic steatohepatit...

    journal_title：Hepatology international

    pub_type： 杂志文章

    doi：10.1007/s12072-012-9395-y

    authors： Kakazu E,Kondo Y,Ninomiya M,Kimura O,Nagasaki F,Ueno Y,Shimosegawa T

    更新日期：2013-06-01 00:00:00

  • An open-label phase I/II study of tamibarotene in patients with advanced hepatocellular carcinoma.

    abstract：AIM:Tamibarotene is a synthetic retinoid expected to inhibit tumor-cell proliferation and to induce apoptosis by selective interaction with retinoic acid receptor α/β. We conducted an open-label phase I/II study to determine the maximum tolerated dose (MTD) and recommended dose (RD), and to evaluate the pharmacokinetic...

    journal_title：Hepatology international

    pub_type： 杂志文章

    doi：10.1007/s12072-013-9459-7

    authors： Kanai F,Obi S,Fujiyama S,Shiina S,Tamai H,Mochizuki H,Koike Y,Imamura J,Yamaguchi T,Saida I,Yokosuka O,Omata M

    更新日期：2014-01-01 00:00:00

  • Hepatocellular adenoma: what is new in 2008.

    abstract：:Patients (85%) with hepatocellular adenoma (HCA) are women taking oral contraceptives. They can be divided into four subgroups according to their genotype/phenotype features. (1) Hepatocyte nuclear factor 1alpha (HNF1alpha) biallelic somatic mutations are observed in 35% of the HCA cases. It occurs in almost all cases...

    journal_title：Hepatology international

    pub_type： 杂志文章

    doi：10.1007/s12072-008-9075-0

    authors： Bioulac-Sage P,Laumonier H,Laurent C,Zucman-Rossi J,Balabaud C

    更新日期：2008-09-01 00:00:00

  • The therapeutic response of antiviral therapy in HBsAg-positive renal transplant recipients and a long-term follow-up.

    abstract：BACKGROUND:Early prediction of lamivudine (LAM) response by individualized monitoring of serum HBV DNA like roadmap concept, and investigation of the outcome after LAM discontinuation in renal transplant recipients (RTRs) with chronic hepatitis B (CHB). METHODS:We conducted a study on 19 RTRs with HBV infection receiv...

    journal_title：Hepatology international

    pub_type： 杂志文章

    doi：10.1007/s12072-011-9295-6

    authors： Hu TH,Tsai MC,Chen YT,Chien YS,Hung CH,Chen TC,Tseng PL,Chang KC,Yen YH

    更新日期：2012-04-01 00:00:00

  • Tenofovir versus entecavir in lowering the risk of hepatocellular carcinoma development in patients with chronic hepatitis B: a critical systematic review and meta-analysis.

    abstract：BACKGROUND:Controversy exists on whether tenofovir disoproxil fumarate (TDF) is superior to entecavir (ETV) in lowering the risk of hepatocellular carcinoma (HCC) development. This meta-analysis was performed to clarify this issue with critical clinical and methodological considerations. METHODS:PubMed, EMBASE, and Co...

    journal_title：Hepatology international

    pub_type： 杂志文章,meta分析

    doi：10.1007/s12072-019-10005-0

    authors： Li M,Lv T,Wu S,Wei W,Wu X,Ou X,Ma H,Chow SC,Kong Y,You H,Jia J

    更新日期：2020-01-01 00:00:00

  • Ultrasound surveillance for early detection of hepatocellular carcinoma among patients with chronic hepatitis C.

    abstract：BACKGROUND AND AIMS:Ultrasonography is the most frequently used modality in surveillance for HCC among patients with chronic hepatitis C. However, the optimal surveillance interval is still controversial and the usefulness of supplementary tumor marker determination has not been confirmed. METHODS:A total of 243 cases...

    journal_title：Hepatology international

    pub_type： 杂志文章

    doi：10.1007/s12072-009-9145-y

    authors： Sato T,Tateishi R,Yoshida H,Ohki T,Masuzaki R,Imamura J,Goto T,Kanai F,Obi S,Kato N,Shiina S,Kawabe T,Omata M

    更新日期：2009-12-01 00:00:00

  • End-stage liver disease patients with MELD >40 have higher waitlist mortality compared to Status 1A patients.

    abstract：BACKGROUND AND AIMS:Status 1A patients are prioritized over end-stage liver disease (ESLD) for liver transplantation (LT). ESLD patients with high MELD may have higher waitlist mortality than Status 1A patients, and may require LT more urgently. METHODS:Using United Network for Organ Sharing registry data, we retrospe...

    journal_title：Hepatology international

    pub_type： 杂志文章

    doi：10.1007/s12072-016-9735-4

    authors： Ahn J,Bhuket T,Mosadeghi S,Frenette C,Liu B,Wong RJ

    更新日期：2016-09-01 00:00:00

  • Etiopathogenesis of primary biliary cirrhosis: an overview of recent developments.

    abstract：:Substantial advancements in the field of primary biliary cirrhosis (PBC) research have broadened our understanding of this enigmatic disease. Genome-wide studies have identified several new candidate genes involved in the immunoregulatory process, particularly those responsible for antigen presentation and lymphocyte ...

    journal_title：Hepatology international

    pub_type： 杂志文章

    doi：10.1007/s12072-012-9362-7

    authors： Trivedi PJ,Cullen S

    更新日期：2013-03-01 00:00:00

  • Virus-induced hepatocellular carcinoma with special emphasis on HBV.

    abstract：:Hepatocellular carcinoma (HCC) is a common malignant tumor with high lethality, and the hepatitis B virus (HBV) is a chief cause. HBV can accelerate HCC via multiple mechanisms. First, HBV induces immune reactions that lead to repeated hepatic inflammation, fibrosis and a deficient immune microenvironment. Subsequentl...

    journal_title：Hepatology international

    pub_type： 杂志文章,评审

    doi：10.1007/s12072-016-9779-5

    authors： Wang M,Xi D,Ning Q

    更新日期：2017-03-01 00:00:00

  • Natural history of HCV infection.

    abstract：BACKGROUND:There is much controversy surrounding the natural history of hepatitis C virus (HCV) infection. AIMS:The aim of this review was to review the natural history of HCV infection. METHODS:Published English literature was searched via pubmed and then reviewed. RESULTS:Approximately, 75-85% of HCV-infected pers...

    journal_title：Hepatology international

    pub_type： 杂志文章

    doi：10.1007/s12072-012-9355-6

    authors： Sarin SK,Kumar M

    更新日期：2012-10-01 00:00:00

  • A comparison of hepatitis B viral markers of patients in different clinical stages of chronic infection.

    abstract：PURPOSE:Hepatitis B viral markers may be useful for predicting outcomes such as liver-related deaths or development of hepatocellular carcinoma. We determined the frequency of these markers in different clinical stages of chronic hepatitis B infection. METHODS:We compared baseline hepatitis B viral markers in 317 pati...

    journal_title：Hepatology international

    pub_type： 杂志文章

    doi：10.1007/s12072-010-9179-1

    authors： Tong MJ,Hsu L,Hsien C,Kao JH,Durazo FA,Saab S,Blatt LM

    更新日期：2010-04-07 00:00:00

  • MSC-based therapies in solid organ transplantation.

    abstract：:Immunomodulatory cell therapy as a complement to standard pharmacotherapy represents a novel approach to solid organ allograft acceptance. This methodology may allow for a reduced dose of immunosuppressive drug to be administered and thus attenuate the severe side effects associated with long-term immunosuppression su...

    journal_title：Hepatology international

    pub_type： 杂志文章

    doi：10.1007/s12072-013-9509-1

    authors： Benseler V,Obermajer N,Johnson CL,Soeder Y,Dahlke MD,Popp FC

    更新日期：2014-04-01 00:00:00

  • Hepatic encephalopathy in acute-on-chronic liver failure.

    abstract：:The presence of hepatic encephalopathy (HE) within 4 weeks is part of the criteria for defining acute-on-chronic liver failure (ACLF). The pathophysiology of HE is complex, and hyperammonemia and cerebral hemodynamic dysfunction appear to be central in the pathogenesis of encephalopathy. Recent data also suggest that ...

    journal_title：Hepatology international

    pub_type： 杂志文章,评审

    doi：10.1007/s12072-015-9626-0

    authors： Lee GH

    更新日期：2015-10-01 00:00:00

  • De novo combination of lamivudine and adefovir versus entecavir monotherapy for the treatment of naïve HBeAg-negative chronic hepatitis B patients.

    abstract：PURPOSE:Either combination treatment or monotherapy using agents with a high genetic barrier are recommended for hepatitis B e antigen (HBeAg)-negative chronic hepatitis B (CHB). The aim of this study was to compare effect of naïve HBeAg-negative CHB patients with either de novo combination of lamivudine (LAM) and adef...

    journal_title：Hepatology international

    pub_type： 杂志文章

    doi：10.1007/s12072-010-9243-x

    authors： Wang LC,Chen EQ,Cao J,Liu L,Zheng L,Li DJ,Xu L,Lei XZ,Liu C,Tang H

    更新日期：2011-06-01 00:00:00

  • C1QTNF1-AS1 regulates the occurrence and development of hepatocellular carcinoma by regulating miR-221-3p/SOCS3.

    abstract：BACKGROUND:The aim of our study was to explore how C1QTNF1-AS1 regulated miR-221-3p/SOCS3 axis in human hepatocellular carcinoma (HCC). METHODS:Differentially expressed lncRNAs and genes were examined via RNA-seq. GO analysis and KEGG pathway enrichment analysis were carried out based on the function of dys-regulated ...

    journal_title：Hepatology international

    pub_type： 杂志文章

    doi：10.1007/s12072-019-09944-5

    authors： Li H,Zhang B,Ding M,Lu S,Zhou H,Sun D,Wu G,Gan X

    更新日期：2019-05-01 00:00:00

  • Depression, fatigue and neurocognitive deficits in chronic hepatitis C.

    abstract：:Patients with chronic hepatitis C virus (HCV) infection experience a range of symptoms including depression, fatigue and neurocognitive deficits, impairing quality of life. Depression, in particular, may be reactive to increased psychosocial stress, and the physical symptoms of advanced HCV or associated comorbidities...

    journal_title：Hepatology international

    pub_type： 杂志文章,评审

    doi：10.1007/s12072-018-9879-5

    authors： Yeoh SW,Holmes ACN,Saling MM,Everall IP,Nicoll AJ

    更新日期：2018-07-01 00:00:00

  • Liver stiffness measurement in the risk assessment of hepatocellular carcinoma for patients with chronic hepatitis.

    abstract：BACKGROUND/AIMS:[corrected] The risk of hepatocellular carcinoma (HCC) increased with progression of hepatic fibrosis as assessed by liver stiffness measurement (LSM). This study used LSM to assess the risk of HCC presence in patients with chronic hepatitis. METHODS:The patients with liver tumor or chronic hepatitis i...

    journal_title：Hepatology international

    pub_type： 杂志文章

    doi：10.1007/s12072-010-9223-1

    authors： Kuo YH,Lu SN,Hung CH,Kee KM,Chen CH,Hu TH,Lee CM,Changchien CS,Wang JH

    更新日期：2010-10-08 00:00:00